- Home
- HOWL vs INVE Comparison
HOWL vs INVE Comparison
Compare HOWL & INVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- INVE
- Stock Information
- Founded
- HOWL 2017
- INVE 1990
- Country
- HOWL United States
- INVE United States
- Employees
- HOWL N/A
- INVE N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- INVE Computer peripheral equipment
- Sector
- HOWL Health Care
- INVE Technology
- Exchange
- HOWL Nasdaq
- INVE Nasdaq
- Market Cap
- HOWL 53.4M
- INVE 74.2M
- IPO Year
- HOWL 2021
- INVE 1997
- Fundamental
- Price
- HOWL $1.25
- INVE $3.50
- Analyst Decision
- HOWL Strong Buy
- INVE Strong Buy
- Analyst Count
- HOWL 3
- INVE 3
- Target Price
- HOWL $8.33
- INVE $6.50
- AVG Volume (30 Days)
- HOWL 549.7K
- INVE 99.0K
- Earning Date
- HOWL 08-07-2025
- INVE 08-07-2025
- Dividend Yield
- HOWL N/A
- INVE N/A
- EPS Growth
- HOWL N/A
- INVE N/A
- EPS
- HOWL N/A
- INVE 3.12
- Revenue
- HOWL $1,143,000.00
- INVE $25,239,000.00
- Revenue This Year
- HOWL N/A
- INVE N/A
- Revenue Next Year
- HOWL N/A
- INVE $9.00
- P/E Ratio
- HOWL N/A
- INVE $1.12
- Revenue Growth
- HOWL N/A
- INVE N/A
- 52 Week Low
- HOWL $0.60
- INVE $2.86
- 52 Week High
- HOWL $4.18
- INVE $4.35
- Technical
- Relative Strength Index (RSI)
- HOWL 45.36
- INVE 63.68
- Support Level
- HOWL $1.03
- INVE $3.10
- Resistance Level
- HOWL $1.10
- INVE $3.61
- Average True Range (ATR)
- HOWL 0.07
- INVE 0.14
- MACD
- HOWL -0.02
- INVE 0.04
- Stochastic Oscillator
- HOWL 22.81
- INVE 79.25
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has one reportable segment: the IoT Business segment. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific.